about
A digital atlas to characterize the mouse brain transcriptome.Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal careEfficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson diseaseOxidative stress and regulation of Pink1 in zebrafish (Danio rerio)A synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseThe 1-Tosylpentan-3-one Protects against 6-Hydroxydopamine-Induced NeurotoxicityTyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's diseaseDuration-dependence of the effect of treadmill exercise on hyperactivity in attention deficit hyperactivity disorder ratsNeuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in RatsIs X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's diseaseNeuroprotective effects of tadalafil on gerbil dopaminergic neurons following cerebral ischemiaInvestigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems.Interactogeneous: disease gene prioritization using heterogeneous networks and full topology scores.A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease.Effect of treadmill exercise on social interaction and tyrosine hydroxylase expression in the attention-deficit/ hyperactivity disorder rats.Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot studyZhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease ratsCo-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's diseaseInhibition of Apoptosis and Efficacy of Pan Caspase Inhibitor, Q-VD-OPh, in Models of Human Disease.Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In VivoEffects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson's Disease Rat Model.Blood-brain barrier transport of therapeutics via receptor-mediationChronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease.Treadmill exercise ameliorates impairment of spatial learning ability through enhancing dopamine expression in hypoxic ischemia brain injury in neonatal ratsPharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation.Hypoxia inducible factor-1 as a target for neurodegenerative diseases.Chronic neuroprotective effects of low concentration lithium on SH-SY5Y cells: possible involvement of stress proteins and gene expression.Genetics of Cerebellar and Neocortical Expansion in Anthropoid Primates: A Comparative Approach.Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model.The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.The best medicine? The influence of physical activity and inactivity on Parkinson's disease.A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.δ-Aminolevulinate Dehydratase Activity is Stimulated in a MPTP Mouse Model of Parkinson's Disease: Correlation with Myeloperoxidase Activity.Tyrosine hydroxylase assay: a bioassay for aryl hydrocarbon receptor-active compounds based on tyrosine hydroxylase promoter activation.Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor.Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.An exploratory evaluation of tyrosine hydroxylase inhibition in planaria as a model for parkinsonism.Effects of Nogo-A Silencing on TNF-α and IL-6 Secretion and TH Downregulation in Lipopolysaccharide-Stimulated PC12 Cells.
P2860
Q24814475-C5DB37AF-C078-4B86-85DF-F0D7A7FFEE19Q26772285-A60AC0D6-0DD7-48CE-8719-4DF0C1A70A8FQ27304699-384C8037-94E2-420F-8F1E-EB0A100C4495Q28259054-336682C6-5925-42CF-8AF2-47BA1C1C6CD0Q28535834-CA02A054-746F-4BA5-8618-EE37C8281C11Q28830946-637D6BBC-4F47-4445-A76C-658998A651BFQ32176923-09AD757B-BDFF-4984-B44A-B422FB450020Q33353558-84DED4C0-862C-4527-8755-D7DEB3E855ABQ33629859-E36C10C6-767E-4A23-9788-453C450C1189Q33905707-F6006538-3CA3-4F28-A3F2-B7FB5AD91780Q34094521-7A3444EB-6EBD-4B55-A6C1-A28190BB8B9CQ34095331-94767E9F-3E44-4158-8F8F-465ACA6210A4Q34440714-35CDB2AB-6DEA-4149-9060-EEC8EEC9CF71Q34490301-380156F4-637B-4740-848A-EEFEF4DDF644Q34511443-73E0E9FF-FFF3-4AC2-AAC9-5010D9A4AF8BQ34544656-68C10257-62B5-44E0-A433-43742521213EQ34651143-DD84A035-A7FD-4E70-92C2-09AFFCC067D2Q34798682-E9486790-8D6D-461F-AE3D-5896C604B6DEQ35061127-CDA8E95B-73CE-4228-BE66-7BF4FD0A757AQ35390301-B62A8E11-B6D4-4291-A153-2FD17D0E8018Q35830378-D02E0387-F455-4191-A830-FA987008516CQ36360543-6A671F03-EC12-4CD2-BEB9-C85DD6AE8D0FQ36874295-1C78AE3A-98C1-4C3A-8C52-FCB10ABE7E29Q36915459-EAB11B53-BACB-4067-B496-A0C6FFF251E5Q37332387-51193CD9-93E1-4A00-A82E-1F92E0D3E0F0Q37556518-D3E47FE6-FDA0-4689-855F-8428334328F0Q37656913-5CDA038E-3283-42D7-BC6F-53EBA7F06F23Q37921345-2AF3A6F6-7F52-4CBF-B48A-49CAEE11BC71Q38248009-CB0A7F70-C8E8-41CC-AAF5-2A8047DA2904Q38431600-4DC96F11-A98F-4A9E-92CD-896F66043DA4Q38628034-653BDB67-5EEC-4113-A92E-FE41B97F0401Q38835751-D3EC3745-ADB4-4BA7-AFB5-82A11686E8C5Q38914196-D537D00F-7962-4700-A69E-FCCCAD032DEFQ39202524-3C12899C-09FA-4FBB-8900-CD3F38EC8DFBQ39369818-011932AC-3C97-4552-93F8-1F1F0787AA20Q39384475-78E11E76-AE3D-4980-9A81-F08DAFC4B577Q40397682-99036CC9-1696-4CF2-A5F1-6E544F34405BQ42148399-52E1D293-F78D-4CB6-A43A-50546422FEC1Q42173539-37FB2FF9-E4F1-4EEE-B7C1-469D186F3F74Q42178747-B45E943D-FBA0-4346-ACAC-B7AD85C3FA16
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Tyrosine hydroxylase and Parkinson's disease
@ast
Tyrosine hydroxylase and Parkinson's disease
@en
Tyrosine hydroxylase and Parkinson's disease
@nl
type
label
Tyrosine hydroxylase and Parkinson's disease
@ast
Tyrosine hydroxylase and Parkinson's disease
@en
Tyrosine hydroxylase and Parkinson's disease
@nl
prefLabel
Tyrosine hydroxylase and Parkinson's disease
@ast
Tyrosine hydroxylase and Parkinson's disease
@en
Tyrosine hydroxylase and Parkinson's disease
@nl
P2860
P3181
P356
P1476
Tyrosine hydroxylase and Parkinson's disease
@en
P2093
P2860
P2888
P304
P3181
P356
10.1007/BF02741387
P407
P50
P577
1998-06-01T00:00:00Z
P6179
1038245077